Wake Forest WF2304-A172401

Objective

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

National Clinical Trial (NCT) Number: 06418204

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT06418204

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Oncology Studies

Specialties

• Breast Cancer
• Gastrointestinal Cancer
• Cancer
• Lung Cancer

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]